Schott opens new China pharma packaging plant
This article was originally published in Scrip
Executive Summary
Schott has opened a new plant for the production of glass pharmaceutical packaging on its existing site in Suzhou, China. The facility is the first of its kind to be set up in the country by a foreign firm, and will supply primary containers to both domestic and multinational companies. The Chinese market for glass packaging is still dominated by low price products, but demand for Schott's high quality lines is expected to grow along with the overall pharma industry, the German group notes. The 2,500m2 facility has 50 employees and a current annual capacity of more than 100 million ampoules and vials, which can be increased if required.
You may also be interested in...
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: another big deal in radiopharmaceuticals; BioNTech’s ADC pipeline; China CDMOs embrace uncertain future; at look at the rivals in MASH; and industry views on how AI might be transformative.
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: Galderma prepares to take on Dupixent; Pfizer’s plans for Adcetris in DLBCL; Lilly’s donanemab approval delayed again; the psychedelic R&D pipeline; and an interview with BMS’s CDTO Greg Meyers.
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: Bayer won’t split, for now; Pfizer’s next-gen ADC pipeline; oncology dominates investment but other areas grow; goodbye NASH, hello MASH; and BMS’s CEO gives his views on India.